# Parkervision Inc: Form 10-Q for the period ended Jun 30, 2014

- Company: [Parkervision Inc](/companies/prkr.md) (CIK 914139)
- Form: 10-Q
- Filed: 2014-08-11
- Accepted by EDGAR: Aug 11, 2014, 20:04 ET
- Period: 2014-06-30
- Accession: 0000914139-14-000044
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914139/000091413914000044/prkr-20140630x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914139/000091413914000044/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2014-04-01 to 2014-06-30 | $0 | us-gaap:CostOfServices |
| Cost of revenue | 6 months, 2014-01-01 to 2014-06-30 | $0 | us-gaap:CostOfServices |
| Gross profit | 3 months, 2014-04-01 to 2014-06-30 | $0 | us-gaap:GrossProfit |
| Gross profit | 6 months, 2014-01-01 to 2014-06-30 | $0 | us-gaap:GrossProfit |
| Research and development | 3 months, 2014-04-01 to 2014-06-30 | $2.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2014-01-01 to 2014-06-30 | $4.5m | us-gaap:ResearchAndDevelopmentExpense |
| Interest expense | 3 months, 2014-04-01 to 2014-06-30 | $2.3k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2014-01-01 to 2014-06-30 | $3.5k | us-gaap:InterestExpense |
| Net income | 3 months, 2014-04-01 to 2014-06-30 | −$5.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2014-01-01 to 2014-06-30 | −$11.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-04-01 to 2014-06-30 | −$0.06 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2014-01-01 to 2014-06-30 | −$0.12 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months, 2014-04-01 to 2014-06-30 | −$4.0m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Operating cash flow | 6 months, 2014-01-01 to 2014-06-30 | −$8.6m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2014-04-01 to 2014-06-30 | $14.5k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months, 2014-01-01 to 2014-06-30 | $40.6k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2014-06-30 | $442.3k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-06-30 | $22.2m | us-gaap:AssetsCurrent |
| Total assets | at 2014-06-30 | $31.0m | us-gaap:Assets |
| Current liabilities | at 2014-06-30 | $1.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-06-30 | $1.7m | us-gaap:Liabilities |
| Shareholders' equity | at 2014-06-30 | $29.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 18,223 characters.

#### Forward-Looking Statements

We believe that it is important to communicate our future expectations to our shareholders and to the public. This report contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, including, in particular, statements about our future plans, objectives, and expectations contained in this Item. When used in this report and in future filings by us with the Securities and Exchange Commission (“SEC”), the words or phrases “expects”, “will likely result”, “will continue”, “is anticipated”, “estimated” or similar expressions are intended to identify “forward-looking statements.” Readers are cautioned not to place undue reliance on such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results and those presently anticipated or projected, including the risks and uncertainties identified in our annual report on Form 10-K for the fiscal year ended December 31, 2013 (the “Annual Report”) and in this Item 2 of Part I of this quarterly report. Examples of such risks and uncertainties include general economic and business conditions, competition, unexpected changes in technologies and technological advances, the timely development and commercial acceptance of new products and technologies, reliance on key business and sales relationships, reliance on our intellectual property, the outcome of our intellectual property litigation and the ability to obtain adequate financing in the future. We have no obligation to publicly release the results of any revisions which may be made to any forward-looking statements to reflect anticipated events or circumstances occurring after the date of such statements.

#### Corporate Website

We webcast our earnings calls and certain events we participate in or host with members of the investment community in the investor relations section of our website. Additionally, we announce investor information, including news and commentary about our business, financial performance and related matters, SEC filings, notices of investor events, and our press and earnings releases, in the investor relations section of our website (http://ir.parkervision.com). Investors and others can receive notifications of new information posted in the investor relations section in real time by signing up for email alerts and/or RSS feeds. Further corporate governance information, including our governance guidelines, board committee charters, and code of conduct, is also available in the investor relations section of our website under the heading “Corporate Governance.” The content of our website is not incorporated by reference into this quarterly report or in any other report or document we file with the SEC, and any references to our website are intended to be inactive textual references only.

#### Overview

We are in the business of innovating fundamental wireless technologies. We design, develop and market our proprietary radio frequency (“RF”) technologies and products for use in semiconductor circuits for wireless communication products.

We have a three-part growth strategy that includes intellectual property licensing and/or product ventures, intellectual property enforcement, and product and component development, manufacturing and sales. We have launched a licensing/product venture campaign to explore licensing and joint product development opportunities with wireless communications companies that make, use or sell chipsets and/or products that incorporate RF technology. In February 2014, we engaged the intellectual property firm of 3LP Advisors, LLC (“3LP”) to assist in managing our licensing operations. We believe there are a number of wireless communications companies that can benefit from the use of the RF technologies we have developed, whether through a license or, in certain cases, a joint product venture that would include licensing rights. We will pay 3LP success fees as a percentage of net proceeds received by us for licensing and licensing-related transactions. During the first 12 months of the term of their engagement, we will also pay 3LP a monthly retainer, one-half of which will be offset against success fees earned by 3LP.

From time to time we expect to be involved in litigation in order to protect or defend our intellectual property rights. Since 2011, we have been involved in patent infringement litigation against Qualcomm Incorporated (“Qualcomm”) for their unauthorized use of our receiver technology. In October 2013, a jury awarded us $172.7 million in past damages for Qualcomm’s infringement of four of our patents. In June 2014, the district court issued its final ruling overturning the jury’s infringement decision. We have appealed this decision to the U.S. Court of Appeals. In May 2014, we filed a second patent infringement litigation action against Qualcomm, as well as their customer, HTC, for their infringement of seven patents related to different technologies of ours. In June 2014, RPX Corporation and Michael Farmwald filed petitions for *Inter Partes* review with the U.S. Patent and Trademark Office challenging the four patents in our initial Qualcomm infringement case. Refer to “Legal Proceedings” in Note 10 to our financial statements included in Item 1 for a complete discussion of the proceedings in these matters. Litigation is inherently uncertain, and as such, we cannot predict the ultimate outcome of these matters. The unfavorable resolution of one or more of these matters could adversely affect our future business plans.

The law firm of McKool Smith is representing us in both Qualcomm infringement actions on a partial contingency basis. We believe there are funding opportunities available to us for financing our portion of the litigation fees for the May 2014 patent infringement action in return for an additional contingent share of any damages awarded in the case, should we determine that such financing is prudent. We expect to continue to incur a portion of the legal costs related to the initial Qualcomm case, including the fees and costs for appellate counsel, and legal costs to defend against the IPR actions.

Our product development and marketing efforts are focused on our RF technologies in mobile and other communications industries that use RF. We have developed and are actively marketing a number of RF component products to industries that presently use less highly integrated semiconductors than would typically be found in mobile wireless applications. These are applications such as industrial, infrastructure, and military devices. In addition, we are working on the continued development and marketing of RF integrated circuits that function with VIA Telecom’s baseband products for mobile handset customers.

Since 2005, we have generated no product or royalty revenue from our wireless technologies. We have made significant investments in developing and protecting our technologies and products, the returns on which are dependent upon the generation of future revenues for realization.

#### Liquidity and Capital Resources

On March 13, 2014, we completed the sale of an aggregate of 2,666,666 shares of our common stock, at a price of $4.50 per share, to two accredited investors in a private placement transaction pursuant to Rule 506 of Regulation D under the Securities Act of 1933, as amended. The offering represented 2.8% of our outstanding common stock on an after-issued basis. The aggregate net proceeds from this offering, after deduction of offering costs, were approximately $11.9 million and will be used for general working capital purposes. We filed a registration statement on April 7, 2014 to register the resale of the common stock issued in the private placement transaction. The registration statement became effective on May 1, 2014 (File No. 333-195105).

As of June 30, 2014, we had working capital of approximately $20.7 million which represented an increase of approximately $5.5 million from working capital at December 31, 2013. This increase in working capital is a result of approximately $11.9 million in net proceeds from the March 2014 offering and approximately $1.7 million in proceeds from the exercise of stock options and warrants, less approximately $8.6 million to fund operations and approximately $0.5 million used for patents and fixed assets during the first six months of 2014.

Our future business plans call for continued investment in sales, marketing, customer support and product development for our technologies and products, as well as investment in continued protection of our intellectual property, including the prosecution of new patents and defense of existing patents. Our ability to generate revenues sufficient to offset costs is subject to our ability to successfully support our customers in completing their initial product designs incorporating our technologies, our ability to secure a reasonable share of the market through additional product offerings with our customers, our ability to secure new customers for our products or technologies, and/or our ability to defend our intellectual property.

Revenue generated from technology licenses and/or the sale of RF chipsets or component products, if any, in 2014 may not be sufficient to cover our operational expenses, and we expect that our continued losses and use of cash will be funded from available working capital. In addition, we expect that available working capital will be used for initial production start-up costs, including test programs and production tooling, and for litigation expenses to defend our intellectual property.

We believe our current capital resources are sufficient to support our currently projected liquidity requirements through 2014 and beyond. The long-term continuation of our business plan is dependent upon the generation of sufficient revenues from our technologies and/or products to offset expenses. In the event that we do not generate sufficient revenues, we will be required to obtain additional funding through public or private financing and/or reduce operating costs. Failure to generate sufficient revenues, raise additional capital through debt or equity financings, and/or reduce operating costs could have a material adverse effect on our ability to meet our long-term liquidity needs and achieve our intended long-term business objectives.

#### Results of Operations for Each of the Three and Six Months Ended June 30, 2014 and 2013

#### Revenue and Gross Margin

We had no product or royalty revenue for the three and six months ended June 30, 2014 and 2013.

Revenue from litigation awards, including settlements, if any, will be recognized upon final disposition of the litigation, including the outcome of any settlement discussions and/or appeals. Refer to “Legal Proceedings” in note 10 for further discussion of our patent infringement litigation against Qualcomm and others.

#### Research and Development Expenses

Research and development expenses consist primarily of engineering and related management and support personnel costs; fees for outside engineering design services which we use from time to time to supplement our internal resources; amortization and depreciation expense related to our patents and other assets used in product development; prototype production and materials costs, which represent the fabrication and packaging costs for prototype integrated circuits, as well as the cost of supporting components for prototype board development; software licensing and support costs, which represent the annual licensing and support maintenance for engineering design and other software tools; and rent and other overhead costs for our engineering design facility. Personnel costs include share-based compensation amounts which have been determined based on the grant date fair value of equity-based awards to our employees and then recorded to expense over the vesting period of the award.

Our research and development expenses decreased approximately $335,000, or 13%, during the three months ended June 30, 2014 when compared to the same period in 2013. This decrease is primarily due to a decrease in fees for outside design and development services of approximately $284,000 and a decrease in travel expenses of approximately $61,000.

Our research and development expenses decreased approximately $436,000, or 9%, during the six months ended June 30, 2014 when compared to the same period in 2013. This decrease is primarily due to a decrease in fees for outside design and development services of approximately $321,000, a decrease in travel expenses of approximately $69,000, and a decrease in prototype costs of approximately $61,000.

The decrease in outside design and development services and prototype costs for the three and six month periods is a result of the timing of development projects. The decrease in travel costs for the three and six month periods is primarily the result of a decline in international travel related to development projects. We expect a significant percentage of our current working capital will continue to be invested in our research and product development activities. However, cash expenditures for research and product development activities will fluctuate on a quarter to quarter basis depending on the timing of various projects.

#### Marketing and Selling Expenses

Marketing and selling expenses consist primarily of marketing and sales personnel costs, including share-based compensation and travel costs, and outside professional fees. Marketing and selling expenses increased approximately $362,000, or 85% during the three months ended June 30, 2014 when compared to the same period in 2013. Marketing and selling expenses increased approximately $622,000, or 76% during the six months ended June 30, 2014 when compared to the same period in 2013. These increases are primarily due to increases in outside professional fees as a result of certain business development activities, including those related to licensing operations and component products, of approximately $316,000 and $523,000 during the three and six months ended June 30, 2014, respectively.

#### General and Administrative Expenses

General and administrative expenses consist primarily of executive, director, finance and administrative personnel costs, including share-based compensation, and costs incurred for insurance, shareholder relations and outside professional services, including litigation and other legal services.

General and administrative expenses decreased approximately $1,302,000, or 31%, during the three months ended June 30, 2014 when compared to the same period in 2013, primarily as a result of a decrease in share-based compensation of approximately $841,000 and a decrease in litigation fees and expenses of approximately $454,000. General and administrative expenses decreased approximately $2,141,000, or 27%, during the six months ended June 30, 2014 when compared to the same period in 2014, primarily as a result of a decrease in share-based compensation of approximately $799,000 and a decrease in litigation fees and expense of approximately $1,315,000. The decrease in share-based compensation is primarily related to a decrease in performance-based RSUs vesting during the three and six months ended June 30, 2014 when compared to the same period in 2013. Litigation fees and expenses declined substantially following the conclusion of the patent infringement jury trial against Qualcomm in October 2013.

#### Net Loss and Net Loss per Common Share

Our net loss decreased approximately $1,286,000, or 18%, during the three months ended June 30, 2014 when compared to the same period in 2013. This decrease is primarily the result of an $835,000 decrease in share-based compensation expense and a $454,000 decrease in litigation expenses. On a per share basis, our net loss decreased $0.02 per common share, or 25%, for the three months ended June 30, 2014 when compared to the same period in 2013 as a result of a $1,275,000 decrease in operating expenses and a 9.7% increase in the weighted average shares outstanding for the period.

Our net loss decreased approximately $1,976,000, or 15%, during the six months ended June 30, 2014 when compared to the same period in 2013. This decrease is primarily the result of a $770,000 decrease in share-based compensation expense and a $1,315,000 decrease in litigation expenses. On a per share basis, our net loss decreased $0.04 per common share, or 25%, for the six months ended June 30, 2014 when compared to the same period in 2013 as a result of a $1,955,000 decrease in operating expenses and an 11.0% increase in the weighted average shares outstanding for the period.

#### Off-Balance Sheet Transactions, Arrangements and Other Relationships

As of June 30, 2014, we had outstanding warrants to purchase 1,399,204 shares of common stock that were issued in connection with the sale of equity securities in a private placement transaction in November 2010. These warrants have an exercise price of $0.54 per share and a remaining contractual life of approximately 1.4 years. The estimated grant date fair value of these warrants of $355,778 is included in shareholders’ equity in our balance sheets.

#### Critical Accounting Policies

In July 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2013-11 Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”) to provide guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists thereby reducing diversity in practice. The amendments in ASU 2013-11 became effective for the Company on January 1, 2014 and did not have a material impact on the Company’s financial statements.

There have been no other changes in critical accounting policies from those stated in our Annual Report.

## Market risk

As filed, 170 characters.

For the three and six months ended June 30, 2014, there were no material changes from the market risk information disclosed under Item 7A of Part II of our Annual Report.

## Controls and procedures

As filed, 929 characters.

#### Evaluation of Disclosure Controls and Procedures

As of June 30, 2014, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our “disclosure controls and procedures,” as defined in Rule 13a-15(e) under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective as of June 30, 2014.

#### Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(e) under the Exchange Act that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 395 characters.

There have been no material changes from the risk factors disclosed in Item 1A of Part I of our Annual Report. In addition to the information in this quarterly report, the risk factors disclosed in our Annual Report should be carefully considered in evaluating our business because such factors may have a significant impact on our business, operating results, liquidity and financial condition.

Filed Aug 11, 2014.
Source: SEC EDGAR, the filing index for accession 0000914139-14-000044. Last ingested by Listed: Nov 11, 2026, 01:56 ET. No prices; not investment advice.
